M. Keel

Epidemiology · 2005

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Keel trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. A. Dinarello
  2. N. Steigbigel
  3. R. Hotchkiss

Who trusts M. Keel overall

  1. M. Markiewski
  2. Lutz Claes

Papers from M. Keel's perspective

Ordered by how strongly the researchers M. Keel trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Efficacy and safety of recombinant human activated protein C for severe sepsis. (New England Journal of Medicine)
  2. Serial evaluation of the SOFA score to predict outcome in critically ill patients. (Journal of the American Medical Association (JAMA))
  3. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock (Current Infectious Disease Reports)
  4. The epidemiology of sepsis in the United States from 1979 through 2000. (New England Journal of Medicine)
  5. Free Radical Pathways in CNS Injury (Journal of Neurotrauma)
  6. Impact of Basic Research On Tomorrow's MedicineProinflammatory Cytokines
  7. The pathophysiology and treatment of sepsis. (New England Journal of Medicine)
  8. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome (Journal of Pathology)
  9. The systemic inflammatory response syndrome in acute liver failure (Hepatology)
  10. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. (Journal of the American Medical Association (JAMA))

Their papers